We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
Cap. Flow
+$3.02B
Cap. Flow %
5.11%
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$905M
2
NVDA icon
NVIDIA
NVDA
+$592M
3
AMD icon
Advanced Micro Devices
AMD
+$439M
4
AMGN icon
Amgen
AMGN
+$385M
5
ADBE icon
Adobe
ADBE
+$382M

Sector Composition

Rank Sector Weight
1 Technology 14.79%
2 Consumer Discretionary 13.23%
3 Healthcare 12.61%
4 Financials 7.44%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UAA icon
401
Under Armour
UAA
$3B
$25.1M 0.04%
2,854,849
+1,346,095
+89% +$10.4M
LNTH icon
402
Lantheus
LNTH
$6.82B
$25.1M 0.04%
404,681
-359,919
-47% -$24.4M
GO icon
403
Grocery Outlet
GO
$891M
$25M 0.04%
928,377
-274,208
-23% -$7.68M
CIVI
404
DELISTED
Civitas Resources
CIVI
$24.8M 0.04%
362,190
+60,803
+20% +$4.35M
WELL icon
405
Welltower
WELL
$178B
$24.6M 0.04%
+273,024
New +$23.7M
NYT icon
406
New York Times
NYT
$11.6B
$24.5M 0.04%
500,456
-91,113
-15% -$4.02M
RIG icon
407
Transocean
RIG
$5.92B
$24.4M 0.04%
3,838,543
+2,609,631
+212% +$17.5M
FUL icon
408
H.B. Fuller
FUL
$3B
$24.2M 0.04%
297,865
-124,287
-29% -$9.18M
NVO
409
Novo Nordisk
NVO
$216B
$24.2M 0.04%
+233,879
New +$23.1M
TS icon
410
Tenaris
TS
$29.1B
$24.2M 0.04%
694,813
-802,890
-54% -$26.9M
LLY icon
411
PUT
Eli Lilly
LLY
$1.07T
$24M 0.04%
41,200
+31,400
+320% +$18.3M
CFR icon
412
Cullen/Frost Bankers
CFR
$10.3B
$24M 0.04%
221,246
-17,267
-7% -$1.68M
MLM icon
413
Martin Marietta Materials
MLM
$33.6B
$23.9M 0.04%
47,920
-130,003
-73% -$58.6M
HALO icon
414
Halozyme
HALO
$9.72B
$23.9M 0.04%
646,168
-2,078,643
-76% -$78.3M
BRK.B icon
415
PUT
Berkshire Hathaway Class B
BRK.B
$1.07T
$23.7M 0.04%
66,400
-9,800
-13% -$3.44M
TOST icon
416
Toast
TOST
$16.8B
$23.6M 0.04%
+1,294,959
New +$21.2M
XOM icon
417
PUT
ExxonMobil
XOM
$651B
$23.6M 0.04%
236,500
+231,100
+4,280% +$24.3M
COIN icon
418
Coinbase
COIN
$41.7B
$23.6M 0.04%
135,908
-24,026
-15% -$2.62M
ELAN icon
419
Elanco Animal Health
ELAN
$12.4B
$23.5M 0.04%
1,577,744
+1,274,406
+420% +$14.4M
GOOS
420
Canada Goose Holdings
GOOS
$868M
$23.4M 0.04%
+1,974,915
New +$23.4M
KRE icon
421
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
$23.4M 0.04%
445,900
-823,200
-65% -$36.8M
ALGN icon
422
Align Technology
ALGN
$12B
$23.3M 0.04%
85,012
+38,318
+82% +$9.08M
DGX icon
423
Quest Diagnostics
DGX
$25.1B
$23.2M 0.04%
168,337
+166,348
+8,363% +$21.9M
CPRT icon
424
Copart
CPRT
$25.9B
$22.9M 0.04%
+467,577
New +$22.1M
SMG icon
425
ScottsMiracle-Gro
SMG
$4.03B
$22.9M 0.04%
358,817
-86,350
-19% -$4.66M

Similar funds

Marshall Wace's Q4 2023 Portfolio in Review

As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.

  • Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
  • Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
  • Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
  • Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
  • Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.